vs

Side-by-side financial comparison of MediWound Ltd. (MDWD) and PURE CYCLE CORP (PCYO). Click either name above to swap in a different company.

PURE CYCLE CORP is the larger business by last-quarter revenue ($9.1M vs $5.7M, roughly 1.6× MediWound Ltd.). PURE CYCLE CORP runs the higher net margin — 50.0% vs -233.3%, a 283.3% gap on every dollar of revenue. On growth, PURE CYCLE CORP posted the faster year-over-year revenue change (58.8% vs 12.7%).

MediWound Ltd. is a biopharmaceutical company specializing in the research, development, production and commercialization of innovative products for burn care, chronic wound treatment and soft tissue repair. It operates mainly across North America, Europe and Asia, serving hospitals, healthcare providers and patients in the wound care segment.

Pure Cycles, is a bicycle company based in Los Angeles, California that was founded by Michael Fishman, Jordan Schau, Zachary Schau and Austin Stoffers in 2010, as Pure Fix Cycles.

MDWD vs PCYO — Head-to-Head

Bigger by revenue
PCYO
PCYO
1.6× larger
PCYO
$9.1M
$5.7M
MDWD
Growing faster (revenue YoY)
PCYO
PCYO
+46.1% gap
PCYO
58.8%
12.7%
MDWD
Higher net margin
PCYO
PCYO
283.3% more per $
PCYO
50.0%
-233.3%
MDWD

Income Statement — Q2 FY2025 vs Q1 FY2026

Metric
MDWD
MDWD
PCYO
PCYO
Revenue
$5.7M
$9.1M
Net Profit
$-13.3M
$4.6M
Gross Margin
23.5%
68.4%
Operating Margin
-100.1%
48.0%
Net Margin
-233.3%
50.0%
Revenue YoY
12.7%
58.8%
Net Profit YoY
-111.2%
16.0%
EPS (diluted)
$-1.23
$0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MDWD
MDWD
PCYO
PCYO
Q4 25
$9.1M
Q3 25
$11.2M
Q2 25
$5.7M
$5.1M
Q1 25
$4.0M
Q4 24
$5.8M
Q3 24
$12.6M
Q2 24
$5.1M
$7.6M
Q1 24
$3.2M
Net Profit
MDWD
MDWD
PCYO
PCYO
Q4 25
$4.6M
Q3 25
$6.1M
Q2 25
$-13.3M
$2.3M
Q1 25
$809.0K
Q4 24
$3.9M
Q3 24
$6.6M
Q2 24
$-6.3M
$2.8M
Q1 24
$118.0K
Gross Margin
MDWD
MDWD
PCYO
PCYO
Q4 25
68.4%
Q3 25
67.7%
Q2 25
23.5%
63.4%
Q1 25
38.2%
Q4 24
63.8%
Q3 24
77.8%
Q2 24
8.8%
64.0%
Q1 24
55.6%
Operating Margin
MDWD
MDWD
PCYO
PCYO
Q4 25
48.0%
Q3 25
53.1%
Q2 25
-100.1%
26.0%
Q1 25
-33.2%
Q4 24
29.9%
Q3 24
62.0%
Q2 24
-88.6%
40.3%
Q1 24
-11.5%
Net Margin
MDWD
MDWD
PCYO
PCYO
Q4 25
50.0%
Q3 25
54.5%
Q2 25
-233.3%
43.9%
Q1 25
20.3%
Q4 24
68.4%
Q3 24
52.6%
Q2 24
-124.5%
37.2%
Q1 24
3.7%
EPS (diluted)
MDWD
MDWD
PCYO
PCYO
Q4 25
$0.19
Q3 25
$0.26
Q2 25
$-1.23
$0.09
Q1 25
$0.03
Q4 24
$0.16
Q3 24
$0.27
Q2 24
$-0.68
$0.12
Q1 24
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MDWD
MDWD
PCYO
PCYO
Cash + ST InvestmentsLiquidity on hand
$1.1M
$17.1M
Total DebtLower is stronger
$8.0M
Stockholders' EquityBook value
$20.1M
$147.5M
Total Assets
$67.0M
$168.1M
Debt / EquityLower = less leverage
0.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MDWD
MDWD
PCYO
PCYO
Q4 25
$17.1M
Q3 25
$21.9M
Q2 25
$1.1M
$14.4M
Q1 25
$16.5M
Q4 24
$19.0M
Q3 24
$22.1M
Q2 24
$3.8M
$20.5M
Q1 24
$20.6M
Total Debt
MDWD
MDWD
PCYO
PCYO
Q4 25
$8.0M
Q3 25
$6.8M
Q2 25
$6.9M
Q1 25
$6.9M
Q4 24
$6.9M
Q3 24
$6.9M
Q2 24
Q1 24
Stockholders' Equity
MDWD
MDWD
PCYO
PCYO
Q4 25
$147.5M
Q3 25
$142.7M
Q2 25
$20.1M
$136.7M
Q1 25
$134.4M
Q4 24
$133.6M
Q3 24
$129.7M
Q2 24
$17.9M
$123.2M
Q1 24
$120.4M
Total Assets
MDWD
MDWD
PCYO
PCYO
Q4 25
$168.1M
Q3 25
$162.3M
Q2 25
$67.0M
$151.7M
Q1 25
$149.7M
Q4 24
$149.7M
Q3 24
$147.4M
Q2 24
$57.3M
$140.4M
Q1 24
$135.2M
Debt / Equity
MDWD
MDWD
PCYO
PCYO
Q4 25
0.05×
Q3 25
0.05×
Q2 25
0.05×
Q1 25
0.05×
Q4 24
0.05×
Q3 24
0.05×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MDWD
MDWD
PCYO
PCYO
Operating Cash FlowLast quarter
$-5.8M
$-979.0K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
-0.21×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MDWD
MDWD
PCYO
PCYO
Q4 25
$-979.0K
Q3 25
$9.4M
Q2 25
$-5.8M
$-503.0K
Q1 25
$-1.4M
Q4 24
$5.7M
Q3 24
$3.1M
Q2 24
$-3.6M
$892.0K
Q1 24
$-457.0K
Cash Conversion
MDWD
MDWD
PCYO
PCYO
Q4 25
-0.21×
Q3 25
1.53×
Q2 25
-0.22×
Q1 25
-1.70×
Q4 24
1.44×
Q3 24
0.47×
Q2 24
0.32×
Q1 24
-3.87×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MDWD
MDWD

Segment breakdown not available.

PCYO
PCYO

Construction$6.5M71%
Water And Wastewater Resource Development Segment$2.5M27%

Related Comparisons